393 related articles for article (PubMed ID: 24405813)
1. Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication.
Munagala S; Sirasani G; Kokkonda P; Phadke M; Krynetskaia N; Lu P; Sharom FJ; Chaudhury S; Abdulhameed MD; Tawa G; Wallqvist A; Martinez R; Childers W; Abou-Gharbia M; Krynetskiy E; Andrade RB
Bioorg Med Chem; 2014 Feb; 22(3):1148-55. PubMed ID: 24405813
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of pentacyclic strychnos alkaloids as selective modulators of the ABCC10 (MRP7) efflux pump.
Teijaro CN; Munagala S; Zhao S; Sirasani G; Kokkonda P; Malofeeva EV; Hopper-Borge E; Andrade RB
J Med Chem; 2014 Dec; 57(24):10383-90. PubMed ID: 25419978
[TBL] [Abstract][Full Text] [Related]
3. Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.
Etievant C; Barret JM; Kruczynski A; Perrin D; Hill BT
Invest New Drugs; 1998; 16(1):3-17. PubMed ID: 9740539
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.
Susa M; Choy E; Yang C; Schwab J; Mankin H; Hornicek F; Duan Z
J Biomol Screen; 2010 Mar; 15(3):287-96. PubMed ID: 20150589
[TBL] [Abstract][Full Text] [Related]
5. Nitensidine A, a guanidine alkaloid from Pterogyne nitens, is a novel substrate for human ABC transporter ABCB1.
Tajima Y; Nakagawa H; Tamura A; Kadioglu O; Satake K; Mitani Y; Murase H; Regasini LO; Bolzani Vda S; Ishikawa T; Fricker G; Efferth T
Phytomedicine; 2014 Feb; 21(3):323-32. PubMed ID: 24135452
[TBL] [Abstract][Full Text] [Related]
6. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH
Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076
[TBL] [Abstract][Full Text] [Related]
7. Leucoridines A-D, cytotoxic Strychnos-Strychnos bisindole alkaloids from Leuconotis.
Gan CY; Etoh T; Hayashi M; Komiyama K; Kam TS
J Nat Prod; 2010 Jun; 73(6):1107-11. PubMed ID: 20515042
[TBL] [Abstract][Full Text] [Related]
8. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
[TBL] [Abstract][Full Text] [Related]
9. Novel pyxinol amide derivatives bearing an aliphatic heterocycle as P-glycoprotein modulators for overcoming multidrug resistance.
Yu L; Ren R; Li S; Zhang C; Chen C; Lv H; Zou Z; Pei X; Song Z; Zhang P; Wang H; Yang G
Eur J Med Chem; 2024 Jun; 272():116466. PubMed ID: 38704938
[TBL] [Abstract][Full Text] [Related]
10. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
11. Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.
Joshi P; Vishwakarma RA; Bharate SB
Eur J Med Chem; 2017 Sep; 138():273-292. PubMed ID: 28675836
[TBL] [Abstract][Full Text] [Related]
12. Monoterpene indole alkaloid azine derivatives as MDR reversal agents.
Paterna A; Khonkarn R; Mulhovo S; Moreno A; Madeira Girio P; Baubichon-Cortay H; Falson P; Ferreira MU
Bioorg Med Chem; 2018 Jan; 26(2):421-434. PubMed ID: 29233614
[TBL] [Abstract][Full Text] [Related]
13. Epimagnolin A, a tetrahydrofurofuranoid lignan from Magnolia fargesii, reverses ABCB1-mediated drug resistance.
Mitani Y; Satake K; Tsukamoto M; Nakamura I; Kadioglu O; Teruya T; Yonezawa T; Cha BY; Efferth T; Woo JT; Nakagawa H
Phytomedicine; 2018 Dec; 51():112-119. PubMed ID: 30466608
[TBL] [Abstract][Full Text] [Related]
14. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells.
Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC
Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405
[TBL] [Abstract][Full Text] [Related]
15. Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
Fong WF; Shen XL; Globisch C; Wiese M; Chen GY; Zhu GY; Yu ZL; Tse AK; Hu YJ
Bioorg Med Chem; 2008 Apr; 16(7):3694-703. PubMed ID: 18313307
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.
Ren Q; Yang G; Guo M; Guo J; Li Y; Lu J; Yang Q; Tang H; Li Y; Fang X; Sun Y; Qi JG; Tian J; Wang H
Eur J Med Chem; 2019 Jan; 161():118-130. PubMed ID: 30347326
[TBL] [Abstract][Full Text] [Related]
17. Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
Hou W; Meng Y; Xu XF; Huang ZX; Liu J; Wang ZY; Lin J; Chen WM
Eur J Med Chem; 2019 Dec; 183():111726. PubMed ID: 31585275
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors.
Hung CC; Chen CY; Wu YC; Huang CF; Huang YC; Chen YC; Chang CS
Eur J Med Chem; 2020 Sep; 201():112422. PubMed ID: 32569926
[TBL] [Abstract][Full Text] [Related]
19. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein.
Liu Z; Zhu H; Qu S; Tang L; Cao L; Yu W; Yang X; Jiang S; Zhu D; Tan C; Yu L
Anticancer Agents Med Chem; 2018; 18(2):286-294. PubMed ID: 28782465
[TBL] [Abstract][Full Text] [Related]
20. Dregamine and tabernaemontanine derivatives as ABCB1 modulators on resistant cancer cells.
Paterna A; Kincses A; Spengler G; Mulhovo S; Molnár J; Ferreira MU
Eur J Med Chem; 2017 Mar; 128():247-257. PubMed ID: 28189906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]